期刊文献+

胃癌PCNA和CD44V6表达的相互关系及其临床意义的研究 被引量:2

Clinical significance of PCNA and CD44V6 expression in gastric cancer
暂未订购
导出
摘要 目的 研究增殖细胞核抗原 (PCNA)和CD44V6表达与胃癌侵袭转移及预后的关系 ,探讨胃癌组织PCNA和CD44V6表达的相互关系。方法 采用SP免疫组化染色方法 ,检测 90例胃癌组织PCNA和CD44V6的表达情况。结果 胃癌组织PCNA标记指数 (LI)为6 3 83 %± 17 16 % ,CD44V6阳性表达率为 74 4% (6 7 90 ) ;PCNALI和CD44V6表达强度与胃癌淋巴结转移、浸润深度及TNM分期均呈显著正相关 (P <0 .0 5 ) ;PCNALI≥ 5 0 %或CD44V6强阳性表达的胃癌患者术后 1,3 ,5年生存率均显著降低 (P <0 .0 5 ) ;CD44V6阳性表达胃癌组织的PCNALI显著高于CD44V6阴性表达者 (P <0 .0 5 )。结论 PCNA和CD44V6表达与胃癌侵袭转移及预后显著相关 ; Objective To study the correlation between the expressions of PCNA and CD44V6 with the tumor invasion and metastasis, and prognosis in patients with gastric cancer(GC), and to evaluate the relationship between the expression of PCNA and CD44V6 in GC. Methods The expression of PCNA and CD44V6 was detected in 90 resected GC specimens with strptavidin peroxidase immunohistochemistry method. Results The mean PCNA LI in gastric cancer was 63.85%±17.16%; the positive rate of CD44V6 expression was 74.4%(67/90). The PCNA LI and staining intensity of CD44V6 were significantly correlated with the lymph node metastasis, depth of invasion, and the TNM stage classification of GC(P<0.05). In patients with high PCNA LI(50% or greater) or strong CD44V6 expression, the 1,3,5 years survival rate were significantly decreased(P<0.05). The PCNA LI in patients with positive CD44V6 expression was significant higher than that in patients with negative CD44V6 expression(P<0.05). Conclusions The PCNA and CD44V6 expression are significantly correlated with the invasion and metastasis and patients' prognosis of GC, the expression of CD44V6 may benefit increase in GC cell proliferative activity.
出处 《中国普通外科杂志》 CAS CSCD 2000年第4期318-320,共3页 China Journal of General Surgery
关键词 胃肿瘤/遗传学 基因表达 增殖细胞核抗原 CD44V6 肿瘤转移 预后 STOMACH/genet GENE EXPRESSION PCNA CD44V6 NEOPLASM METASTASIS PROGNOSIS
  • 相关文献

参考文献11

  • 1Tubiano M,Pejovic MH,Koscilny S,et al.Growthrate,kinetics of tumor cell proliferation and long term outcome in human breast cancer[J].IntJ Cancer,1989,44(1):17-22.
  • 2Robbins BA,Delavegn D,Ogatak,et al.Immunohistochemical detection of proliferatingcell nuclear antigen in solid human malignancies[J].Arch Pathol LabMed,1987,11(7):841-845.
  • 3Kaufmann M,Heider KH,Sinn HP,et al.CD44V6 variant exon epitopes in primary breastcancer and length of survival[J].Lancet,1995,345(5):615-618.
  • 4Kennedy BJ.The unified international gastric cancer staging classification system[J].ScandJ Gastroenteral,1987,22(suppl 133):11-14.
  • 5Maeda K,Chung YS,Ohada N,et al.Proliferating cell nuclear antigen labeling index ofpro/eoperative biopsy specimens in gastric carcinoma with special reference to prognosis[J].Cancer,1994,73:528-533.
  • 6梁雨荣,何尔斯泰,郑泽霖.PCNA及DNA含量与胃癌预后关系的研究[J].中国肿瘤临床,1997,24(8):594-598. 被引量:8
  • 7Gunthert U,Hofmann M,Rudy W,et al.A variant of glycoprotein CD44 confer metastaticpotential to rat carcinoma cells[J].Cell,1991,65(1):12-17.
  • 8Washington K,Grottfried MK,Teren MJ.Expression of the cell adhesion mocular CD44 ingastric adenocarcinomas[J].Hum Pathol,1994,25(12):1843-1094
  • 9Mayer B,Jauch KW,Gunthert U,et al.De-navo expression of CD44 and survival ingastric cancer[J].Lancet,1993,342(9):1019-1022.
  • 10周烨.增殖细胞核抗原与胃癌浸润、转移和预后的关系[J].实用癌症杂志,1998,13(3):232-234. 被引量:6

二级参考文献1

共引文献11

同被引文献19

  • 1张卫强,王云杰,林华,周勇安,程庆书,刘锟,李小飞,王小平.N-cadherin在非小细胞肺癌组织中的表达及临床生物学意义[J].第四军医大学学报,2005,26(2):157-159. 被引量:4
  • 2Lascombe I,Clairotte A,Fauconnet S,Bernardini S,Wallerand H,Kantelip B,Bittard H.N-cadherinas a novel prognostic marker of progression in su-perficial urothelial tumors.Clin Cancer Res2006;12:2780-2787.
  • 3Alexander NR,Tran NL,Rekapally H,Summers CE,Glackin C,Heimark RL.N-cadherin gene ex-pression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1.Cancer Res2006;66:3365-3369.
  • 4Hatta K,Takeichi M.Expression of N-cadherin ad-hesion molecules associated with early morphoge-netic events in chick development.Nature1986;320:447-449.
  • 5Volk T,Geiger B.A135-kd membrane protein ofintercellular adherens junctions.EMBO J1984;3:2249-2260.
  • 6Andersson AM,Edvardsen K,Skakkebaek NE.Ex-pression and localization of N-and E-cadherin in the human testis and epididymis.Int J Androl1994;17:174-180.
  • 7Cavallaro U.N-cadherin as an invasion promoter:a novel target for antitumor therapy Curr Opin In-vestig Drugs2004;5:1274-1278.
  • 8Mosnier JF,Kandel C,Cazals-Hatem D,Bou-Hanna C,Gournay J,Jarry A,Laboisse CL.N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas.Mod Pathol2009;22:182-190.
  • 9Mariotti A,Perotti A,Sessa C,Rüegg C.N-cadherin as a therapeutic target in cancer.Expert Opin Inves-tig Drugs2007;16:451-465.
  • 10Giussani P,Brioschi L,Bassi R,Riboni L,Viani P.Phosphatidylinositol3-kinase/AKT pathway regulates the endoplasmic reticulum to golgi traf-fic of ceramide in glioma cells:a link between lipid signaling pathways involved in the control of cell survival.J Biol Chem2009;284:5088-5096.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部